|
LMTK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.063500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.334610E-01 |
| Normal-vs-Stage2 |
2.388800E-01 |
| Normal-vs-Stage3 |
3.922200E-01 |
| Normal-vs-Stage4 |
2.217400E-01 |
| Stage1-vs-Stage2 |
5.771400E-01 |
| Stage1-vs-Stage3 |
9.255600E-01 |
| Stage1-vs-Stage4 |
5.566400E-02 |
| Stage2-vs-Stage3 |
7.018600E-01 |
| Stage2-vs-Stage4 |
8.480400E-02 |
| Stage3-vs-Stage4 |
1.300230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.775200E-03 |
| Normal-vs-AfricanAmerican |
8.355000E-01 |
| Normal-vs-Asian |
1.158360E-01 |
| Caucasian-vs-AfricanAmerican |
9.843700E-03 |
| Caucasian-vs-Asian |
8.736200E-03 |
| AfricanAmerican-vs-Asian |
4.776200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.673900E-02 |
| Normal-vs-Female |
9.821000E-03 |
| Male-vs-Female |
1.557350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.920800E-01 |
| Normal-vs-Extreme_Weight |
5.100800E-01 |
| Normal-vs-Obese |
2.124100E-02 |
| Normal-vs-Extreme_Obese |
4.355800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.212400E-01 |
| Normal_Weight-vs-Obese |
2.091200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.512400E-01 |
| Extreme_Weight-vs-Obese |
1.862350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.736000E-01 |
| Obese-vs-Extreme_Obese |
9.283000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.758600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.875990E-03 |
| Normal-vs-Age(61-80Yrs) |
2.323600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.422000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.849360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.497200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.237400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.169700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.876800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.380100E-03 |
| Normal-VS-Type2 PRCC |
4.196200E-01 |
| Normal-VS-KIRP CIMP |
5.063200E-01 |
| Normal-VS-Unclassified PRCC |
2.845900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.468000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.988200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.624800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.963400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.683500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.983400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.306200E-01 |
| Normal-vs-N1 |
4.871600E-01 |
| Normal-vs-N2 |
9.209600E-01 |
| N0-vs-N1 |
6.470200E-01 |
| N0-vs-N2 |
9.685600E-01 |
| N1-vs-N2 |
8.372600E-01 |
|
|
